These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38532435)

  • 1. Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study.
    Druckrey-Fiskaaen KT; Vold JH; Madebo T; Midgard H; Dalgard O; Leiva RA; Fadnes LT;
    Subst Abuse Treat Prev Policy; 2024 Mar; 19(1):21. PubMed ID: 38532435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands.
    van Santen DK; Schim van der Loeff MF; Cartier van Dissel J; Martens JPD; van der Valk M; Prins M
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1168-1176. PubMed ID: 30028776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C.
    van Santen DK; Agius PA; Sasadeusz J; Fairley CK; Sievert W; Gane E; Iser D; O'Reilly M; Medland NA; Moore R; Hellard ME; Hoy JF; Doyle JS;
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):e81-e89. PubMed ID: 32842055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outreach screening of drug users for cirrhosis with transient elastography.
    Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
    Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange - evaluated with liver elasticity.
    Kåberg M; Edgren E; Hammarberg A; Weiland O
    Scand J Gastroenterol; 2019 Mar; 54(3):319-327. PubMed ID: 30907178
    [No Abstract]   [Full Text] [Related]  

  • 7. Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis.
    Babakinejad P; Lapsley R; Forster L; McPherson S; Pearce MS; Reynolds NJ; Slack E; Weatherhead SC; Hampton PJ
    Br J Dermatol; 2024 Jul; 191(2):275-283. PubMed ID: 38366967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
    Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection.
    Chen Yi Mei SLG; Thompson AJ; Christensen B; Cunningham G; McDonald L; Bell S; Iser D; Nguyen T; Desmond PV
    PLoS One; 2017; 12(10):e0185609. PubMed ID: 29065124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study.
    Christiansen KM; Mössner BK; Hansen JF; Jarnbjer EF; Pedersen C; Christensen PB
    PLoS One; 2014; 9(11):e111912. PubMed ID: 25369038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study.
    Lee HW; Wong GL; Kwok R; Choi KC; Chan CK; Shu SS; Leung JK; Chim AM; Luk AO; Ma RC; Chan HL; Chan JC; Kong AP; Wong VW
    Hepatology; 2020 Oct; 72(4):1230-1241. PubMed ID: 31991487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
    Behairy Bel-S; Sira MM; Zalata KR; Salama el-SE; Abd-Allah MA
    World J Gastroenterol; 2016 Apr; 22(16):4238-49. PubMed ID: 27122674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
    Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
    J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.
    Bloom S; Kemp W; Nicoll A; Roberts SK; Gow P; Dev A; Bell S; Sood S; Kronborg I; Knight V; Lewis D; Lubel J
    J Hepatol; 2018 Sep; 69(3):575-583. PubMed ID: 29709676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
    Kirk GD; Astemborski J; Mehta SH; Spoler C; Fisher C; Allen D; Higgins Y; Moore RD; Afdhal N; Torbenson M; Sulkowski M; Thomas DL
    Clin Infect Dis; 2009 Apr; 48(7):963-72. PubMed ID: 19236273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.
    Solomon SS; Srikrishnan AK; McFall AM; Kumar MS; Saravanan S; Balakrishnan P; Solomon S; Thomas DL; Sulkowski MS; Mehta SH
    PLoS One; 2016; 11(1):e0147879. PubMed ID: 26812065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography.
    Rout G; Nayak B; Patel AH; Gunjan D; Singh V; Kedia S; Shalimar
    J Clin Exp Hepatol; 2019; 9(2):207-214. PubMed ID: 31024203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.
    John BV; Dang Y; Kaplan DE; Jou JH; Taddei TH; Spector SA; Martin P; Bastaich DR; Chao HH; Dahman B
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):778-788.e7. PubMed ID: 38061410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.